Company profile
AnaMar AB company profile
AnaMar AB, a Swedish-based drug discovery company, is developing orally bioavailable, peripherally acting 5-HT2B receptor antagonists designed to prevent pathological fibrotic processes. The company is operative in discovery and the early phases of drug development, from the idea stage to clinical trials. This includes invention and optimization of new drug candidates, evaluation of preclinical efficacy and safety and finally, confirmatory early clinical studies in patients with fibrotic disease.
Business identity
- Website
- http://anamar.com/
- Contact email
- [email protected]
- Phone number
- +46 46 275 62 50
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $0+
- Founded
- 1998-01-01
Headquarters
- Headquarters
- Byumba, Northern Province, Rwanda
- Postal code
- 223 81
- Country code
- RW
- Continent
- Africa